Skip to content
Login

EPLAW Patent Blog: latest European patent law developments

With thanks to our sponsors

https://www.danubia.com/
https://www.linklaters.com/
https://www.brinkhof.com/
https://www.twobirds.com/
https://www.stibbe.com/
https://www.wr.no/
https://www.barentskrans.nl/
https://www.simmons-simmons.com/
https://www.lagro.com/
https://www.bristows.com/
https://www.danubia.com/
https://simontbraun.eu/
https://roa.pl/
https://www.lenzstaehelin.com/
https://www.eplaw.org/about/dr-j-alingh-prins-fund/
https://www.gassauer.com/
https://www.pinsentmasons.com/
https://www.roschier.com/
https://www.hoyngrokhmonegier.com/
https://www.freshfields.com/
https://powellgilbert.com/
https://www.arnold-siedsma.com/
https://www.plesner.com/
https://www.bardehle.com/
https://www.arnold-ruess.com/en
https://www.coupry.nl/
https://www.vondst.com/
27 February 2025
News – EPLAW Webinar on Plausibility
27 February 2025
UPC – Joint Ceiling on Recoverable Costs
27 February 2025
News – Book: Case law – Court of Appeal of the UPC 2023-2024
26 February 2025
CJEU – Comment Prof. Willem Hoyng on BSH Hausgeräte v. Electrolux
25 February 2025
CJEU – BSH Hausgeräte v. Electrolux
21 February 2025
NL – Sandoz / Teva v. Bristol-Myers Squibb – Supreme Court Decision
19 February 2025
UPC – Abbott Diabetes Care v. Sibio Technology / Provisional measures Appeal
17 February 2025
News – Registration Young EPLAW 2025 now open
14 February 2025
UPC – First Annual Report Published
13 February 2025
UPC – Suinno v. Microsoft / Appeal
11 February 2025
News – Save the dates: Two new EPLAW webinars
07 February 2025
UK – Genentech & Novartis’ omalizumab formulation patent held valid and infringed by Celltrion

EPLAW Patent Blog

Get the latest European patent law developments

BLOG